Statistical Evaluation of ERG Responses: A New Method to Validate Cycle-by-Cycle Recordings in Advanced Retinal Degenerations
Investigative Opthalmology & Visual Science · 2024
DOI: 10.1167/iovs.65.4.3 ↗At a glance
Journal article in Investigative Opthalmology & Visual Science, 2024. Written by Antonello Fadda and 6 co-authors. Institution: Department of Cardiovascular and Endocrine-Metabolic Diseases, and Ageing, National Institute of Health, Rome, Italy. Major MEDLINE topics: Retinal Degeneration, Color Vision Defects. Cited 1 times so far (Crossref); 22 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Purpose
To describe and evaluate a novel method to determine the validity of measurements made using cycle-by-cycle (CxC) recording techniques in patients with advanced retinal degenerations (RD) having low-amplitude flicker electroretinogram (ERG) responses.
Methods
The method extends the original CxC recording algorithm introduced by Sieving et al., retaining the original recording setup and the preliminary analysis of raw data. Novel features include extended use of spectrum analysis, reduction of errors due to known sources, and a comprehensive statistical assessment using three different tests. The method was applied to ERG recordings from seven patients with RD and two patients with CNGB3 achromatopsia.
Results
The method was implemented as a Windows application to processes raw data obtained from a commercial ERG system, and it features a computational toolkit for statistical assessment of ERG recordings with amplitudes as low as 1 µV, commonly found in advanced RD patients. When recorded using conditions specific for eliciting cone responses, none of the CNGB3 patients had a CxC validated response, indicating that no signal artifacts were present with our recording conditions. A comparison of the presented method with conventional 30 Hz ERG was performed. Bland-Altman plots indicated good agreement (mean difference, -0.045 µV; limits of agreement, 0.193 to -0.282 µV) between the resulting amplitudes. Within-session test-retest variability was 15%, comparing favorably to the variability of standard ERG amplitudes.
Conclusions
This novel method extracts highly reliable clinical recordings of low-amplitude flicker ERGs and effectively detects artifactual responses. It has potential value both as a cone outcome variable and planning tool in clinical trials on natural history and treatment of advanced RDs.
Subjects
MeSH terms (MEDLINE)
Authors and institutions
- Department of Cardiovascular and Endocrine-Metabolic Diseases, and Ageing, National Institute of Health, Rome, Italy.
- Ophthalmic Genetics and Visual Function Branch, National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States.
- UOC Oculistica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
- Department of Ophthalmology, University of California, Davis, Davis, California, United States.
- Department of Ophthalmology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
- Ospedale Pediatrico Bambino Gesù IRCCS, Rome, Italy.
Cite
APA
Fadda, A., Martelli, F., Zein, W. M., Jeffrey, B., Placidi, G., Sieving, P. A., & Falsini, B. (2024). Statistical Evaluation of ERG Responses: A New Method to Validate Cycle-by-Cycle Recordings in Advanced Retinal Degenerations. Investigative Opthalmology & Visual Science. https://doi.org/10.1167/iovs.65.4.3
Vancouver
Fadda A, Martelli F, Zein WM, Jeffrey B, Placidi G, Sieving PA, et al. Statistical Evaluation of ERG Responses: A New Method to Validate Cycle-by-Cycle Recordings in Advanced Retinal Degenerations. Investigative Opthalmology & Visual Science. 2024. doi:10.1167/iovs.65.4.3
BibTeX
@article{Fadda2024,
author = {Fadda, Antonello and Martelli, Francesco and Zein, Wadih M and Jeffrey, Brett and Placidi, Giorgio and Sieving, Paul A and Falsini, Benedetto},
title = {Statistical Evaluation of ERG Responses: A New Method to Validate Cycle-by-Cycle Recordings in Advanced Retinal Degenerations},
journal = {Investigative Opthalmology & Visual Science},
year = {2024},
doi = {10.1167/iovs.65.4.3}
}
EUVIMED